InvestSMART

Cryosite Limited (ASX: CTE) - Announcements

- Current share price for CTE : $1.220

ASX company news and announcements for Cryosite Limited (CTE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cryosite Limited (CTE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cryosite Limited (CTE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cryosite Limited (CTE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$60 ACCC ends review of Cell Care's Cryosite assets acquisition 21 Dec 2017 9:31AM $0.125 $1.220 risen by 876%
$60 Notice of General Meeting/Proxy Form 14 Dec 2017 8:46AM $0.135 $1.220 risen by 803.70%
$60 Appendix 3B 1 Dec 2017 2:25PM $0.135 $1.220 risen by 803.70%
$60 Appendix 3B 28 Nov 2017 10:30AM $0.135 $1.220 risen by 803.70%
$60 Trading update 22 Nov 2017 9:08AM $0.150 $1.220 risen by 713.33%
$60 ACCC update 8 Nov 2017 8:20AM $0.150 $1.220 risen by 713.33%
$60 Results of Meeting 3 Nov 2017 11:10AM $0.135 $1.220 risen by 803.70%
$60 Chairman's Address to Shareholders 3 Nov 2017 10:25AM $0.135 $1.220 risen by 803.70%
$60 Change of Director's Interest Notice 11 Oct 2017 10:50AM $0.150 $1.220 risen by 713.33%
$60 Notice of Annual General Meeting/Proxy Form 29 Sep 2017 11:12AM $0.130 $1.220 risen by 838.46%
$60 Appendix 4G and Corporate Governance Statement 23 Aug 2017 7:08PM $0.165 $1.220 risen by 639.39%
$60 Appendix 4E and Annual Report 23 Aug 2017 6:55PM $0.165 $1.220 risen by 639.39%
$60 ACCC review of proposed transaction of Cord Blood assets 4 Aug 2017 8:37AM $0.180 $1.220 risen by 577.78%
$60 Change in substantial holding 3 Jul 2017 2:13PM $0.160 $1.220 risen by 662.50%
$60 Change of Director's Interest Notice 3 Jul 2017 2:11PM $0.160 $1.220 risen by 662.50%
$60 Appendix 3c - share buyback 23 Jun 2017 11:42AM $0.160 $1.220 risen by 662.50%
$60 Cryosite to license its CB&T brand and sell certain assets 23 Jun 2017 11:41AM $0.160 $1.220 risen by 662.50%
$60 Appointment of Interim CEO 15 Jun 2017 9:36AM $0.180 $1.220 risen by 577.78%
$60 Resignation of CEO 19 May 2017 9:46AM $0.180 $1.220 risen by 577.78%
$60 CEO - introduction of short and long term incentive plan 8 Mar 2017 10:17AM $0.200 $1.220 risen by 510%
$60 Appendix 3B - performance rights 8 Mar 2017 10:13AM $0.200 $1.220 risen by 510%
$60 Dividend/Distribution - CTE 22 Feb 2017 11:44AM $0.190 $1.220 risen by 542.11%
$60 Appendix 4D and Half Year Accounts 22 Feb 2017 11:44AM $0.190 $1.220 risen by 542.11%
$60 Revised Share Trading Policy 7 Feb 2017 2:36PM $0.190 $1.220 risen by 542.11%
$60 Change of Director's Interest Notice 6 Jan 2017 9:51AM $0.175 $1.220 risen by 597.14%

201 - 225 of 328 results

Page 9 of 14

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.